发明名称 Somatic gene therapy to suppress secondary cataract formation following eye surgery
摘要 Disclosed is a replication-recombinant virus, preferably an adenovirus that lacks E1a, E1b and E4 ORF 6, capable of infecting an eye and comprising a lens epithelial cell specific promoter driving an ORF encoding at least one protein, which when expressed in lens epithelial cells of an eye suppresses, at the level of the germinative epithelium of the lens of the eye, cellular proliferation which is stimulated by eye surgery and which would otherwise result in secondary cataract formation in the eye. Also disclosed is the use of the recombinant virus for the treatment of an eye, undergoing eye (e.g. cataract) surgery, in order to reduce the incidence of cellular proliferation in the eye following the surgery and thereby to prevent the formation of secondary cataracts.
申请公布号 US2003219412(A1) 申请公布日期 2003.11.27
申请号 US20030386330 申请日期 2003.03.11
申请人 UNIVERSITY OF LAUSANNE, AN INSTITUTION ORGANIZED AND EXISTING UNDER THE LAWS OF SWITZERLAND 发明人 SHAW PHILLIP HERBERT;SAHLI ROLAND;SICKENBERG MICHEL;MUNIER FRANCIS
分类号 C12N15/09;A61K35/76;A61K48/00;A61P27/12;C07K14/47;C07K14/82;C12N7/00;C12N15/861;(IPC1-7):A61K48/00 主分类号 C12N15/09
代理机构 代理人
主权项
地址